Meeting
2020 ASCO Virtual Scientific Program
Multiple myeloma (MM) vaccination (influenza, FV and pneumococcal, PV) rates worldwide and impact on infection, hospitalization, and death.
Authors
Michael A. Thompson
Aurora Cancer Care, Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI
Michael A. Thompson , Caitlin Costello , Jesus G. Berdeja , Faith Davies , Jeffrey A. Zonder , Hans Chulhee Lee , Jim Omel , Andrew Spencer , Evangelos Terpos , Vania Hungria , Noemi Puig , Cheng-Cheng Fu , Tomas Skacel , Renda H. Ferrari , Kaili Ren , Dawn Marie Stull , Ajai Chari
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies
Sub Track
Multiple Myeloma
Clinical Trial Registration Number
NCT02761187
Citation
J Clin Oncol 38: 2020 (suppl; abstr 8528)
DOI
10.1200/JCO.2020.38.15_suppl.8528
Abstract #
8528
Poster Bd #
428
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Quality Care Symposium
Safety and efficacy of COVID-19 vaccination in patients receiving systemic anticancer therapy.
First Author: Mahir Khan
Poster
2023 ASCO Annual Meeting
Efficacy of COVID vaccinations in patients with chronic lymphocytic leukemia.
First Author: Kaitlin Annunzio
Poster
2023 ASCO Annual Meeting
Treatment patterns for extramedullary multiple myeloma and outcomes with CAR-T therapy and bispecific antibodies.
First Author: Saurabh Zanwar
Poster
2023 ASCO Genitourinary Cancers Symposium
Clinical characteristics and outcomes of SARS-CoV-2 infection in patients with genitourinary cancer.
First Author: Dorothy Kenny